PROS1 and COVID-19: In summary, these data suggest that PROS1 regulation of coagulation, complement activation, and pro-inflammatory activation of myeloid cells, as well as promoting their communication with effector T cells, may be the mechanisms by which PROS1 limits pathogenic myeloid cell responses during SARS-CoV-2 infection and protects against severe COVID-19.